Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Immunotherapy
1
Impact of immunotherapy on liver metastasis
7/22/2024 11:57:17 AM |
Browse: 9 |
Download: 11
2
Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma
7/16/2024 6:17:55 AM |
Browse: 18 |
Download: 28
3
Managing immune checkpoint inhibitor-associated gastritis: Insights and strategies
6/25/2024 10:41:21 AM |
Browse: 17 |
Download: 24
4
Comparative effectiveness of immunotherapy and chemotherapy in patients with metastatic colorectal cancer stratified by microsatellite instability status
4/22/2024 9:51:56 AM |
Browse: 31 |
Download: 118
5
Immune checkpoint inhibitor-associated gastritis: Patterns and management
4/12/2024 4:45:44 PM |
Browse: 42 |
Download: 128
6
Approaches and challenges in cancer immunotherapy pathways
3/22/2024 11:48:13 AM |
Browse: 62 |
Download: 139
7
Revolutionizing gastric cancer treatment: The potential of immunotherapy
1/26/2024 7:56:28 AM |
Browse: 136 |
Download: 212
8
Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023)
10/27/2023 3:28:49 PM |
Browse: 164 |
Download: 504
9
Progress in immunotherapy for neuroendocrine neoplasm of the digestive system
7/10/2023 8:58:21 AM |
Browse: 147 |
Download: 356
10
Immunotherapy for advanced gastric cancer
6/20/2023 11:28:13 AM |
Browse: 174 |
Download: 374
11
Low-dose immunotherapy as a potentiator to increase the response with neo-adjuvant chemotherapy in oral cancers
6/12/2023 8:16:26 AM |
Browse: 151 |
Download: 284
12
Immunotherapy for recurrent hepatocellular carcinoma
4/14/2023 1:45:13 PM |
Browse: 177 |
Download: 345
13
“Cold” colorectal cancer faces a Bottleneck in immunotherapy
2/15/2023 12:44:08 AM |
Browse: 195 |
Download: 424
14
Conversion therapy for advanced penile cancer with tislelizumab combined with chemotherapy: A case report and review of literature
11/23/2022 9:44:45 AM |
Browse: 199 |
Download: 548
15
Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review
11/21/2022 4:25:35 AM |
Browse: 282 |
Download: 540
16
Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation
11/17/2022 4:40:53 AM |
Browse: 365 |
Download: 773
17
Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy
11/10/2022 9:21:28 AM |
Browse: 271 |
Download: 791
18
Favorable response of primary pulmonary lymphoepithelioma-like carcinoma to sintilimab combined with chemotherapy: A case report
10/27/2022 4:55:05 AM |
Browse: 249 |
Download: 504
19
Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China
10/27/2022 4:55:05 AM |
Browse: 265 |
Download: 708
20
Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
10/27/2022 3:05:58 AM |
Browse: 228 |
Download: 767
21
Longest survival with primary intracranial malignant melanoma: A case report and literature review
10/21/2022 2:24:59 AM |
Browse: 270 |
Download: 554
22
Hypophysitis induced by anti-programmed cell death protein 1 immunotherapy in non-small cell lung cancer: Three case reports
10/21/2022 2:24:59 AM |
Browse: 246 |
Download: 492
23
Autoimmune encephalitis with posterior reversible encephalopathy syndrome: A case report
10/21/2022 2:24:59 AM |
Browse: 252 |
Download: 437
24
Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
10/14/2022 12:54:50 PM |
Browse: 284 |
Download: 1119
25
New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
10/14/2022 8:30:45 AM |
Browse: 273 |
Download: 558
26
Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
9/29/2022 9:17:29 AM |
Browse: 265 |
Download: 560
27
Malignant peritoneal mesothelioma with massive ascites as the first symptom: A case report
9/27/2022 1:00:18 PM |
Browse: 596 |
Download: 637
28
Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
9/23/2022 10:13:16 AM |
Browse: 296 |
Download: 712
29
Neoadjuvant immunotherapy in non-small-cell lung cancer: Times are changing—and fast
9/22/2022 6:32:13 AM |
Browse: 237 |
Download: 477
30
Successful treatment of stage IIIB intrahepatic cholangiocarcinoma using neoadjuvant therapy with the PD-1 inhibitor camrelizumab: A case report
9/16/2022 11:52:44 AM |
Browse: 257 |
Download: 600
31
Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer
9/9/2022 12:48:14 PM |
Browse: 266 |
Download: 1018
32
Implication of gut microbiome in immunotherapy for colorectal cancer
9/9/2022 12:48:14 PM |
Browse: 274 |
Download: 845
33
Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
9/9/2022 12:48:14 PM |
Browse: 249 |
Download: 691
34
Advances in postoperative adjuvant therapy for primary liver cancer
9/9/2022 12:48:14 PM |
Browse: 311 |
Download: 850
35
Treatment of gastric carcinoma with lymphoid stroma by immunotherapy: A case report
8/26/2022 9:54:53 AM |
Browse: 288 |
Download: 832
36
Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma
8/26/2022 9:51:35 AM |
Browse: 252 |
Download: 490
37
Paroxysmal speech disorder as the initial symptom in a young adult with anti-N-methyl-D-aspartate receptor encephalitis: A case report
8/16/2022 1:35:32 AM |
Browse: 229 |
Download: 525
38
Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”
8/1/2022 9:20:54 AM |
Browse: 343 |
Download: 873
39
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
7/27/2022 2:48:53 AM |
Browse: 332 |
Download: 499
40
Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities
7/27/2022 2:48:53 AM |
Browse: 296 |
Download: 470
41
Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy
7/22/2022 9:38:18 AM |
Browse: 353 |
Download: 713
42
Nanomedicine approaches for treatment of hematologic and oncologic malignancies
7/22/2022 9:38:18 AM |
Browse: 328 |
Download: 693
43
Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
7/18/2022 9:47:46 AM |
Browse: 352 |
Download: 742
44
Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report
7/11/2022 8:36:01 AM |
Browse: 278 |
Download: 690
45
Advances and effectiveness of the immunotherapy after liver transplantation
6/27/2022 9:34:47 AM |
Browse: 358 |
Download: 777
46
Primary squamous cell carcinoma of the liver: A case report
6/24/2022 9:00:25 AM |
Browse: 309 |
Download: 837
47
Chidamide and sintilimab combination in diffuse large B-cell lymphoma progressing after chimeric antigen receptor T therapy
6/24/2022 9:00:24 AM |
Browse: 212 |
Download: 433
48
Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances
6/22/2022 8:29:42 AM |
Browse: 335 |
Download: 631
49
New perspectives in the management of small cell lung cancer
6/22/2022 8:29:42 AM |
Browse: 274 |
Download: 541
50
Camrelizumab-induced anaphylactic shock in an esophageal squamous cell carcinoma patient: A case report and review of literature
6/17/2022 3:19:27 AM |
Browse: 243 |
Download: 763
Page 1 of 5 ( 216 items )
<<
1
2
3
4
5
>>
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345